Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G et al. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology. 2018;68(1):113-26. doi:https://doi.org/10.1002/hep.29789.
2. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25(4):647-55.
3. Bosman FT, Carneiro F, Hruban RH, Theise N, D. WHO classification of tumours of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
4. Wakizaka K, Yokoo H, Kamiyama T, Ohira M, Kato K, Fujii Y et al. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. Journal of gastroenterology and hepatology. 2019;34(6):1074-80. doi:https://doi.org/10.1111/jgh.14547.
5. Rogers JE, Bolonesi RM, Rashid A, Elsayes KM, Elbanan MG, Law L et al. Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy. J Gastrointest Oncol. 2017;8(2):347-51. doi:https://doi.org/10.21037/jgo.2017.03.03.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献